With tanker traffic through the strait dropping by 90%, it's not hard to draw a straight line between the ongoing conflict and widespread supply chain disruptions.
Companies remain caught between a court ruling that invalidated the tariffs, and a government that has yet to fully acknowledge how it intends to unwind them.
President Donald Trump had previously vowed to offer insurance guarantees and possible U.S. Navy escorts to oil tankers transiting the Strait of Hormuz.
Trade unpredictability exposes vulnerabilities in the pharmaceutical supply chain that must be addressed to build resilient systems ensuring patient access despite geopolitical challenges.
If nearshoring and regional strategies are to work properly, companies need to have resilient and flexible supply chains, says Matt Schroeder, president of WSI/Kase.